South China Biomedical Co., Ltd. is building a world-class biotechnology company. It is a high-tech biopharmaceutical technology company based on stem cells and regenerative medicine, driven by clinical translational research and application of cell therapy, and focused on precision medicine, assisted reproduction, and health management. Through its layout and efforts across the entire big health industry chain, it aims to build a world-class biotechnology company. Bo'ai Kangmin is a wholly-owned subsidiary of South China.
The company has advanced cell technology, has built * cell laminar flow culture rooms, created a scientific and efficient clinical application research system for cells, and has rich experience in clinical cell research.
As a state-owned listed company with the Hunan Provincial Government as the actual controller and Hunan Caixin Financial Holdings Group as the *** largest shareholder, South China Biology takes "universal love for the people, benefiting the public" as its mission, deeply cultivates the biotechnology industry, and promotes a new leap in human health.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
